Newstral
Article
bizjournals.com on 2015-07-23 16:42
Foundation provides new twist in Teva-Mylan saga
Related news
- Mylan/Teva saga could be resolved in an Amsterdam courtbizjournals.com
- Mylan foundation to block Teva pharma’s hostile takeover bidtimesofisrael.com
- Teva drops bid for Mylan, buys Allergan's generic drug unitbizjournals.com
- Report: Teva getting ready to up its offer for Mylanbizjournals.com
- Foundation triggers Mylan takeover defense seen as a roadblock for Teva bidtriblive.com
- Teva takes its case for buying Mylan to the company's stockholdersbizjournals.com
- Teva drops bid for Mylan, buys Allergan's generic drug unit for $40.5 billionbizjournals.com
- Teva makes $40.1B unsolicited bid for MylanThe Salt Lake Tribune
- Mylan chief: Acquisition by Teva not feasibleHaaretz
- Teva offers to buy Mylan for $40.1Bobserver-reporter.com
- Teva makes $40B offer for MylanArkansas Online
- Teva buying Allergan, drops Mylan bidPhilly.com
- Teva accuses Mylan of suppressing bidThe Salt Lake Tribune
- Teva ends hostile bid for Mylanbizjournals.com
- Teva still targets Mylan despite rejectionThe Jerusalem Post (JPost.com)
- The Teva vs. Mylan drug warThe Jerusalem Post (JPost.com)
- Teva buying up shares of Mylanbizjournals.com
- Teva accuses Mylan of ‘desperate attempt’ to suppress bidThe Findlay Courier
- Consumer groups urge FTC to block Teva takeover of Mylanbizjournals.com